Selected Publications

Boldanova T, Suslov A, Heim MH and Necsulea A. (2017) Transcriptional response to hepatitisC virus infection and interferon-alpha treatment in the human liver. EMBO Mol MedHeim MH, Bochud PY and George J. (2016) Host – hepatitis C viral interactions: The role ofgenetics. J Hepatol 65, S22–32

Dazert E, Colombi M, Boldanova T, Moes S, Adametz D, Quagliata L, Roth V, Terracciano L,Heim MH, Jenoe P, Hall MN. (2016) Quantitative proteomics and phosphoproteomics onserial tumor biopsies from a sorafenib-treated HCC patient. Proc Natl Acad Sci U S A 113,1381–1386

Makowska Z, Boldanova T, Adametz D, Quagliata L, Vogt JE, Dill MT, Matter MS, Roth V, TerraccianoL and Heim MH. (2016) Gene expression analysis of biopsy samples reveals criticallimitations of transcriptome-based molecular classifications of hepatocellular carcinoma.J Pathol Clin Res 2, 80–92

Terczynska-Dyla E, Bibert S, Duong FH, Krol I, Heim MH, Bochud PY, Hartmann R. (2014) ReducedIFNlambda4 activity is associated with improved HCV clearance and reduced expressionof interferon-stimulated genes. Nat Commun 5, 5699

Heim MH. (2013). 25 years of interferon-based treatment of chronic hepatitis C: an epochcoming to an end. Nat Rev Immunol 13, 535–542